Physician profile
Eddie Mas
NPI 1154315554
$449.28
in general payments reported to CMS, 2019-2025
14 companies · $34.60 in 2025
The $34.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $28.20 · 2021: $35.19 · 2022: $15.18 · 2023: $118 · 2024: $99.70 · 2025: $34.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $94.06 | 2019-2024 | |
| Astellas Pharma US INC | $91.73 | 2023-2024 | Veozah |
| Amgen INC. | $45.77 | 2022-2025 | Prolia, Evenity |
| Therapeuticsmd, INC. | $35.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.67 | 2020-2023 | |
| Radiometer America, INC | $27.61 | 2023 | |
| Sanofi Pasteur INC. | $21.99 | 2019 | |
| Medtronic, INC. | $21.03 | 2021 | |
| Becton, Dickinson and Company | $19.35 | 2023 | Bd Onclarity |
| Lupin INC. | $16.65 | 2019 | |
| Smith+Nephew, INC. | $15.87 | 2023 | Grafix Pl, Oasis Micro, Grafix Xc |
| Roche Diagnostics Corporation | $14.16 | 2021 | |
| Abbvie INC. | $14.03 | 2019 | |
| Organon LLC | $4.01 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Mas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.